Form Type: 4

SEC EDGAR Link
Accession Number:0001363213-15-000026
Date:2015-07-06
Issuer: SCICLONE PHARMACEUTICALS INC (SCLN)
Original Submission Date:

Reporting Person:

BLOBEL FRIEDHELM
950 TOWER LANE, SUITE 900
FOSTER CITY, CA 94404

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2015-07-06 M 20,000 a $2.49 222,273 direct
COMMON STOCK 2015-07-06 S 20,000 d $10.80 202,273 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 2.49 2015-07-06 deemed execution date M 20,000 (d) 2016-06-02 common stock 20,000 $2.49 629,360 direct
Footnotes
IDfootnote
f1 the reported sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 11, 2014.
f2 granted under the issuer's 2005 equity incentive plan.
f3 provided the reporting person remains employed by or acting as a consultant to the company, the option will become exercisable in four equal annual installments on 6/02/07, 6/02/08, 6/02/09 and 6/02/10.
WhaleWisdom Logo

Elevate your investments